Cord Blood Derived CAR-T Cells in Refractory/Relapsed B Cell Malignancies
Clinical trial NCT03881774 · UNKNOWN
Trial details
- NCT number
- NCT03881774
- Sponsor
- Henan Cancer Hospital
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-02-27
- Primary completion
- 2021-01-31
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.